Zefia Hall

DNP Doctor of Nursing Practice,  Mayo Clinic - Rochester 

Location: Germany

Consulting Services

Pharma-CRO-Device Sales and Marketing Biostatistics Data Science-Bioinformatics Grant Submission

Areas Of Interest

Acylglycerol Infection, HTLV-II Agonist, GABA-A Receptor M13 Phage Amyloid beta Protein Precursor Truncation Bias Dysautonomia, Primary Tumor, Grawitz Sciences, Exercise Nutritional Cerebral Circulations Officials, Government Syndrome, Cardio-Cutaneous Polyglactin D Component of Complement Metathesaurus Receptor Kinases, G-Protein-Coupled p Bromdylamine Abnormalities, Autosome Phosphokinase, Choline Psychological Generalizations Body Pattern Specification GM-CSF Giant Cell Carcinoma Chromophobe Adenomas Intersectoral Cooperation Cholinergic System, Non-Neuronal Amethopterin v-H-ras Oncogene Streams MARylation indicas, Tamarindus Macular Neuroretinopathy, Acute Nuclei, Posterior Thalamic Parencephalon Syndrome, Cast Kanokonlit Cadherin Associated Protein 102 kDa

Professional Narrative

Dr. Zefia Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Mayo Clinic 2004
Executive Director, Harvard Med 1997

Education

Master of Science in physician assistant, Baylor College 2004
Director Medicine, Baylor College 2007

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :